Company / SG&A per Share
Moderna SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.64
FY2025
5-year range
$0.28 / $4.02
FY2021-FY2025
Trend
-14.2%
vs FY2024
Sector context
#71 of 210
Health Care
What the data says
At $2.64, Moderna's sg&a per share ranks #140 of 210 in the Health Care sector. SG&A per Share has fluctuated over the past 10 years, ranging from $0.28 in FY2021 to $4.02 in FY2023.
Based on SEC 10-K filings.
2.64 in FY2025 with a 5-year CAGR of +36.4%.
Improved from $4.02 to $2.64 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +78.1%
- 5-Year CAGR
- +36.4%
- 10-Year CAGR
- -
Sector benchmark
#140 of 210 in Health CareTop 66% of 210This company $2.64 Sector average $40.75
▼
-93.5% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 14.2% year-over-year.
- Ranks #71 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2023.
- Lowest sg&a per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.64 | -14.2% |
| FY2024 | $3.07 | -23.6% |
| FY2023 | $4.02 | +762.5% |
| FY2022 | $0.47 | +69.2% |
| FY2021 | $0.28 | -50.6% |
| FY2020 | $0.56 | +67.0% |
| FY2019 | $0.33 | -76.9% |
| FY2018 | $1.45 | +44.0% |
| FY2017 | $1.00 | +6.1% |
| FY2016 | $0.95 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026